Browse > Article
http://dx.doi.org/10.4062/biomolther.2007.15.2.089

Fermented Ginseng with Bifidobacterium Inhibits Angiogenesis of Human Umbilical Endothelial Cells in vitro and in vivo  

Ko, Yu-Jin (College of Pharmacy, Yeungnam University)
Park, Seung-Hee (R&D Center, Jung San Biotechnology)
Park, Byung-Chul (College of Pharmacy, Yeungnam University)
Lee, Yong-Hwa (R&D Center, Jung San Biotechnology)
Kim, Jung-Ae (College of Pharmacy, Yeungnam University)
Publication Information
Biomolecules & Therapeutics / v.15, no.2, 2007 , pp. 89-94 More about this Journal
Abstract
Ginseng is a widely-used alternative medicine for the treatment of cancer, diabetes, and cardiovascular diseases. Active components of P. ginseng, absorbed through gastrointestinal tract are the fermented ginsenosides by intestinal microorganisms. In the present study, we investigated the inhibitory effects of fermented ginseng with bifidobacterium (FGb) on the angiogenesis by analyzing in vitro tube formation and invasion assay using human umbilical vein endothelial cells (HUVECs), and in vivo angiogenesis using chick chorioallantoic membrane (CAM) assay. Treatment with FGb inhibited tube-like structure formation in a concentration-dependent manner. In addition, FGb significantly suppressed HUVEC invasion through Matrigel. Moreover, FGb dosedependently inhibited VEGF-induced angiogenesis in a CAM assay. These results suggest that FGb is a valuable anti-angiogenic remedy.
Keywords
Fermenta ginseng; Angiogenesis; Tube formation; Migration; Chick chorioallantoic membrane;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Hasegawa, H., Sung, J.H., Matsumiya, S. and Uchiyama, M. (1996). Main ginseng saponin metabolites formed by intestinal bacteria. Planta Med. 62, 453-457   DOI   ScienceOn
2 Liang, H.C., Chen, C.T., Chang, Y., Huang, Y.C., Chen, S.C. and Sung, H.W. (2005). Loading of a novel angiogenic agent, ginsenoside Rg1 in an acellular biological tissue for tissue regeneration. Tissue Eng. 11, 835-846   DOI   ScienceOn
3 Akao, T., Kida, H., Kanaoka, M., Hattori, M. and Kobashi, K. (1998). Intestinal bacterial hydrolysis is required for the appearance of compound K in rat plasma after oral administration of ginsenoside Rb1 from Panax ginseng. J. Pharm. Pharmacol. 50, 1155-1160   DOI   ScienceOn
4 Blouw, B., Song, H., Tihan, T., Bosze, J., Ferrara, N., Gerber, H.P., Johnson, R.S. and Bergers, G.. (2003). The hypoxic response of tumors is dependent on their microenvironment. Cancer Cell. 4, 133-146   DOI   ScienceOn
5 Folkman, J. (1971). Tumor angiogenesis: therapeutic implications. N. Engl. J. Med. 285, 1182-1186   DOI   ScienceOn
6 Hasegawa, H., Sung, J.H., Matsumiya, S., Uchiyama, M., Inoue, Y., Kasai, R. and Yamasaki, K. (1995). Reversal of daunomycin and vinblastin resistance in multidrug resistant P388 leukemia in vitro through enhanced cytotoxicity by triterpenoids. Planta Med. 61, 409-413   DOI   ScienceOn
7 Hasegawa, H., Sung, J.H. and Huh J.D. (1997a). Ginseng intestinal bacteria metabolite IH901 as a new antimetastatic agent. Arch. Pharm. Res. 20, 539-544   DOI   ScienceOn
8 Hasegawa, H., Sung, J.H. and Benno, Y. (1997b). Role of human intestinal Prevotella oris in hydrolyzing ginseng saponins. Planta Med. 63, 436-440   DOI   ScienceOn
9 Hasegawa, H., Lee, K.S., Nagaoka, T., Tezuka, Y., Uchiyama, M., Kadota, S. and Saiki, I. (2000). Pharmacokinetics of ginsenoside deglycosylated by intestinal bacteria and its transformation to biologically active fatty acid esters. Biol. Pharm. Bull. 23, 298-304   DOI   ScienceOn
10 Isner, J.M. and Asahara, T. (1999). Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization. J. Clin. Invest. 103, 1231-1236   DOI   ScienceOn
11 Lin, C.M., Chang, H., Chen, Y.H., Li, S.Y., Wu, I.H. and Chiu, J.H. (2006). Protective role of wogonin against lipopolysaccharide-induced angiogenesis via VEGFR-2, not VEGFR-1. Int. Immunopharmacol. 6, 1690-1698   DOI   ScienceOn
12 Jin, J., Shahi, S., Kang, H.K., van Veen, H.W. and Fan, T.P. (2006). Metabolites of ginsenosides as novel BCRP inhibitors. Biochem. Biophys. Res. Commun. 345, 1308-1314   DOI   ScienceOn
13 Karikura, M., Miyase, T., Tanizawa, H., Taniyama, T. and Takino, Y. (1991). Studies on absorption, distribution, excretion and metabolism of ginseng saponins. VII. Comparison of the decomposition modes of $ginsenoside-Rb_1$ and -$Rb_2$ in the digestive tract of rats. Chem. Pharm. Bull. (Tokyo). 39, 2357-2361   DOI   ScienceOn
14 Leung, K.W., Pon, Y.L., Wong, R.N. and Wong, A.S. (2006). Ginsenoside-Rg1 induces vascular endothelial growth factor expression through the glucocorticoid receptor-related phosphatidylinositol 3-kinase/Akt and beta-catenin/T-cell factordependent pathway in human endothelial cells. J. Biol. Chem. 281, 36280-36288   DOI   ScienceOn
15 Liu, C.X. and Xiao, P.G., (1992). Recent advances on ginseng research in China. Int. Immunopharmacol.36, 27-38
16 Liu, W.K., Xu, S.X. and Che, C.T. (2000). Anti-proliferative effect of ginseng saponins on human prostate cancer cell line. Life Sci. 67, 1297-1306   DOI   ScienceOn
17 Mochizuki, M., Yoo, Y.C., Matsuzawa, K., Sato, K., Saiki, I., Tono-oka, S., Samukawa, K. and Azuma, I. (1995). Inhibitory effect of tumor metastasis in mice by saponins, ginsenoside-$Rb_{2}$, 20(R)- and 20(S)-ginsenoside-$Rg_{3}$, of red ginseng. Biol. Pharm. Bull. 18, 1197-1202   DOI   ScienceOn
18 Sengupta, S., Toh, S.A., Sellers, L.A., Skepper, J.N., Koolwijk, P., Leung, H.W., Yeung, H.W., Wong, R.N., Sasisekharan, R. and Fan, T.P. (2004). Modulating angiogenesis: the yin and the yang in ginseng. Circulation. 110, 1219-1225   DOI   ScienceOn
19 Mousa, S.A., Mohamed, S., Wexler, E.J. and Kerr, J.S. (2005). Antiangiogenesis and anticancer efficacy of TA138, a novel alphavbeta3 antagonist. Anticancer Res. 25, 197-206
20 Rosenblatt, M.I. and Azar, D.T. (2006). Anti-angiogenic therapy: Prospects for treatment of ocular tumors. Semin. Ophthalmol. 21, 151-160   DOI   ScienceOn
21 Yue, P.Y., Wong, D.Y., Wu, P.K., Leung, P.Y., Mak, N.K., Yeung, H.W., Liu, L., Cai, Z., Jiang, Z.H., Fan, T.P. and Wong, R.N. (2006). The angiosuppressive effects of 20(R)-ginsenoside $Rg_{3}$. Biochem. Pharmacol. 72, 437-445   DOI   ScienceOn
22 Yun, T.K., Lee, Y.S., Lee, Y.H., Kim, S.I. and Yun, H.Y. (2001). Anticarcinogenic effect of Panax ginseng C.A. Meyer and identification of active compounds. J. Korean Med. Sci. 16, S6-18   DOI
23 Shin, H.R., Kim, J.Y., Yun, T.K., Morgan, G. and Vainio, H. (2000). The cancer-preventive potential of Panax ginseng: a review of human and experimental evidence. Cancer Causes Control. 11, 565-576   DOI   ScienceOn
24 Shinkai, K., Akedo, H., Mukai, M., Imamura, F., Isoai, A., Kobayashi, M. and Kitagawa, I. (1996). Inhibition of in vitro tumor cell invasion by ginsenoside $Rg_{3}$. Jpn. J. Cancer Res. 87, 357-362   DOI
25 Xu, Q.F., Fang, X.L. and Chen, D.F. (2003). Pharmacokinetics and bioavailability of ginsenoside $Rb_{1}$ and $Rg_{1}$ from Panax notoginseng in rats. J. Ethnopharmacol. 84, 187-192   DOI   ScienceOn
26 Tanizawa, H., Karikuma, M., Miyase, T. and Takino, Y. (1993). Studies on the metabolism and/or decomposition and distribution of ginsenoside $Rb_{2}$ in rats. Proc. 6th Int. Ginseng Symp. Seoul. p.187-194